A Plus Biotechnology Co., Ltd. (6918.TW) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan
Price
73.30 TWD
Market cap
2.50 bn TWD
P/E (2025)
14.77
P/S (2025)
2.99
Dividend yield
6.82 %
Net margin
20.26 %
Return on equity (ROE)
13.41 %
Return on assets (ROA)
10.93 %
A Plus Biotechnology Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 769.59 m TWD | 835.89 m TWD |
| Gross profit | 534.78 m TWD | 573.46 m TWD |
| Operating income | 182.28 m TWD | 208.76 m TWD |
| EBIT | 189.75 m TWD | 218.31 m TWD |
| Net income | 151.06 m TWD | 169.38 m TWD |
| Diluted EPS – continuing operations | 4.96 TWD | 4.96 TWD |
Full history since 2021, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About A Plus Biotechnology Co., Ltd.
A Plus Biotechnology Co., Ltd. engages in the manufacturing and wholesale of orthopedic and other medical devices. The company offers products for chest, shoulder, spine, elbow, wrist and hand, pelvic and hip, knee, foot and ankle, osteotomy, pediatric and ESF, biologics. It also provides bone grafts. A Plus Biotechnology Co., Ltd. was founded in 2009 and is based in New Taipei City, Taiwan.
More stocks
- Afluente Transmissão de Energia Elétrica S.A (AFLT3.SA)
- VIB Vermoegen (VIH1.DE)
- Crimson Wine Group, Ltd (CWGL)
- DY Corporation (013570.KS)
- Y-Entec Co. Ltd (067900.KQ)
- CeoTronics AG (CEK.DE)
- Taiwan Chelic Corp Ltd (4555.TW)
- FITLIFE BRANDS, INC. (FTLF)
- DHP Korea Co. Ltd (131030.KQ)
- Ifishdeco PT (IFSH.JK)
- XAC Automation (5490.TWO)
- Nongwoobio Co. Ltd (054050.KQ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.